The safety of bevazicumab for the treatment of ovarian cancer
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2018.1532500
Abstract: ABSTRACT Introduction: The safety profile of bevacizumab (BV) remains a challenging issue, in particular its role in fragile OC patients. Areas covered: In this literature review, we have analyzed safety data from Phase III trials… read more here.
Keywords: safety; drug; ovarian cancer; bevazicumab treatment ... See more keywords